These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 3924431

  • 1. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
    Kensler TW, Egner PA, Trush MA, Bueding E, Groopman JD.
    Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431
    [Abstract] [Full Text] [Related]

  • 2. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
    Kensler TW, Egner PA, Davidson NE, Roebuck BD, Pikul A, Groopman JD.
    Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
    [Abstract] [Full Text] [Related]

  • 3. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.
    McLellan LI, Judah DJ, Neal GE, Hayes JD.
    Biochem J; 1994 May 15; 300 ( Pt 1)(Pt 1):117-24. PubMed ID: 8198522
    [Abstract] [Full Text] [Related]

  • 4. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
    Jhee EC, Ho LL, Lotlikar PD.
    Cancer Res; 1988 May 15; 48(10):2688-92. PubMed ID: 3129185
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD.
    Cancer Res; 1987 Aug 15; 47(16):4271-7. PubMed ID: 2886217
    [Abstract] [Full Text] [Related]

  • 6. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
    Mandel HG, Manson MM, Judah DJ, Simpson JL, Green JA, Forrester LM, Wolf CR, Neal GE.
    Cancer Res; 1987 Oct 01; 47(19):5218-23. PubMed ID: 2887284
    [Abstract] [Full Text] [Related]

  • 7. 2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes.
    Ch'ih JJ, Biedrzycka DW, Lin T, Khoo MO, Devlin TM.
    Proc Soc Exp Biol Med; 1989 Oct 01; 192(1):35-42. PubMed ID: 2508094
    [Abstract] [Full Text] [Related]

  • 8. Effect of butylated hydroxyanisole pretreatment on aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in isolated hepatocytes from rats.
    Jhee EC, Ho LL, Tsuji K, Gopalan P, Lotlikar PD.
    Cancer Res; 1989 Mar 15; 49(6):1357-60. PubMed ID: 2493978
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase.
    Thamavit W, Tatematsu M, Ogiso T, Mera Y, Tsuda H, Ito N.
    Cancer Lett; 1985 Jul 15; 27(3):295-303. PubMed ID: 2861889
    [Abstract] [Full Text] [Related]

  • 10. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat.
    Liu YL, Roebuck BD, Yager JD, Groopman JD, Kensler TW.
    Toxicol Appl Pharmacol; 1988 May 15; 93(3):442-51. PubMed ID: 3130679
    [Abstract] [Full Text] [Related]

  • 11. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM, Tanaka T, Maeura Y.
    Carcinogenesis; 1986 Jul 15; 7(7):1043-50. PubMed ID: 2872975
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats.
    Cha YN, Heine HS.
    Cancer Res; 1982 Jul 15; 42(7):2609-15. PubMed ID: 6805943
    [Abstract] [Full Text] [Related]

  • 13. Effect of butylated hydroxyanisole on in vivo and in vitro hepatic aflatoxin B1-DNA binding in rats.
    Lotlikar PD, Clearfield MS, Jhee EC.
    Cancer Lett; 1984 Oct 15; 24(3):241-50. PubMed ID: 6437665
    [Abstract] [Full Text] [Related]

  • 14. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout.
    Goeger DE, Shelton DW, Hendricks JD, Pereira C, Bailey GS.
    Carcinogenesis; 1988 Oct 15; 9(10):1793-800. PubMed ID: 3139317
    [Abstract] [Full Text] [Related]

  • 15. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD, Liu YL, Rogers AE, Groopman JD, Kensler TW.
    Cancer Res; 1991 Oct 15; 51(20):5501-6. PubMed ID: 1680553
    [Abstract] [Full Text] [Related]

  • 16. Lack of influence of butylated hydroxytoluene on modification of lung microsome mediated aflatoxin B1-DNA binding: role of pulmonary glutathione S-transferase.
    Allameh A, Saxena M, Raj HG.
    Cancer Lett; 1988 Dec 01; 43(1-2):125-31. PubMed ID: 3144431
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS, Lalwani ND, Watanabe TK, Reddy JK.
    Cancer Res; 1984 Mar 01; 44(3):1072-6. PubMed ID: 6692393
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM, Iatropoulos MJ.
    Cancer Lett; 1996 Jun 24; 104(1):49-53. PubMed ID: 8640745
    [Abstract] [Full Text] [Related]

  • 19. Effects of butylated hydroxytoluene pretreatment on the metabolism and genotoxicity of aflatoxin B1 in primary cultures of adult rat hepatocytes: selective reduction of nucleic acid binding.
    Salocks CB, Hsieh DP, Byard JL.
    Toxicol Appl Pharmacol; 1984 Dec 24; 76(3):498-509. PubMed ID: 6209823
    [Abstract] [Full Text] [Related]

  • 20. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
    Hayes JD, Judah DJ, Neal GE.
    Cancer Res; 1993 Sep 01; 53(17):3887-94. PubMed ID: 8395332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.